4-氨基-1-(2-氟苄基)哌啶 | 160358-06-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 4-氨基-1-(2-氟苄基)哌啶
• 英文名称: 1-(2-fluorobenzyl)piperidin-4-amine
• 英文别名: 4-amino-1-(2-fluorobenzyl)piperidine；1-[(2-Fluorophenyl)methyl]piperidin-4-amine
• CAS: 160358-06-5
• 化学式: C₁₂H₁₇FN₂
• mdl: MFCD07365306
• 分子量: 208.279
• InChiKey: BOFKUKJMMWHACT-UHFFFAOYSA-N

物化性质

• 沸点：
  282.6±35.0 °C(Predicted)
• 密度：
  1?+-.0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  29.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933399090

反应信息

• 作为反应物：
  描述：

  4-氨基-1-(2-氟苄基)哌啶 以 乙醇 为溶剂， 反应 24.0h， 生成 2-[trans-(4-aminocyclohexyl)amino]-6-[4-[1-(2-fluorobenzyl)]piperidinylamino]-9-cyclopentylpurine
  参考文献：
  名称：

  THE DESIGN AND SYNTHESIS OF PURINE INHIBITORS OF CDK2. III

  摘要：

  Cyclin-dependent kinases (CDKs) belong to a class of enzymes that control the ability of a cell to enter into and proceed through the cell division cycle. Using purine as a scaffold, we have synthesized a number of nanomolar inhibitors of CDK-2/cyclin E. In this report, the synthesis of a series of piperidine-substituted purine analogs will be presented, as well as some of their in vitro and in vivo biological effects.

  DOI：

  10.1081/ncn-100002493
• 作为产物：
  描述：

  4-叔丁氧羰基氨基哌啶 在 sodium hydride 、 三氟乙酸 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 14.0h， 生成 4-氨基-1-(2-氟苄基)哌啶
  参考文献：
  名称：

  Claulansine F–Donepezil Hybrids as Anti-Alzheimer’s Disease Agents with Cholinergic, Free-Radical Scavenging, and Neuroprotective Activities

  摘要：

  阿尔茨海默病（AD）的多因素性质需要开发多靶点药物，以应对关键的病理过程。总共设计和合成了26种Claulansine F-donepezil杂合物作为多靶点药物。在这些化合物中，有六种表现出优秀的乙酰胆碱酯酶（AChE）抑制活性（半最大抑制浓度（IC50）为1.63-4.62μM）。此外，（E）-3-（8-（叔丁基）-3,3-二甲基-3,11-二氢吡喃[3,2-a]咔唑-5-基）-N-（（1-（2-氯苯甲基）哌啶-4-基）甲基）丙烯酰胺（6bd）对OGD/R（氧-葡萄糖剥夺/再氧化）表现出比Claulansine F更好的神经保护作用。此外，6bd在体外可以穿越血脑屏障。更重要的是，与雷达伏酮相比，6bd具有更强的自由基清除活性。分子对接研究揭示了6bd可以与AChE的催化活性位点相互作用。所有这些出色的体外结果表明6bd作为一个值得进一步研究的领先结构。

  DOI：

  10.3390/molecules26051303

文献信息

• [EN] METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION<br/>[FR] PROCÉDÉS ET COMPOSITIONS D'INHIBITION DE L'INTERACTION DCN1-UBC12
  申请人：ST JUDE CHILDREN'S RES HOSPITAL

  公开号：WO2017049295A1

  公开（公告）日：2017-03-23

  In one aspect, the invention relates to substituted l-phenyl-3-(piperidin-4-yl)urea analogs, derivatives thereof, and related compounds, which are useful as inhibitors of the DCN1-UBC12 interaction inhibitors of DCN1 -mediated cullin-RING ligase activity, methods of making same, pharmaceutical compositions comprising same, methods of treating disorders using the disclosed compounds and compositions, methods of treating disorders associated with a DCN1-UBC12 interaction dysfunction, methods of treating disorders associated with a DCN1-mediated cullin-RING ligase activity dysfunction, methods of male contraception comprising the disclosed compounds and compositions, and kits comprising the disclosed compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

  在一个方面，本发明涉及替代的l-苯基-3-(哌啶-4-基)脲类似物，其衍生物和相关化合物，这些化合物可用作DCN1-UBC12相互作用抑制剂和DCN1介导的卡林-环形酶活性抑制剂，制备方法，包含这些化合物的药物组合物，使用所披露的化合物和组合物治疗疾病的方法，治疗与DCN1-UBC12相互作用功能障碍相关的疾病的方法，治疗与DCN1介导的卡林-环形酶活性功能障碍相关的疾病的方法，包含所披露的化合物和组合物的男性避孕方法，以及包含所披露的化合物和组合物的试剂盒。本摘要旨在作为在特定领域进行搜索的扫描工具，并不打算限制本发明。
• Histone lysine methyltransferase structure activity relationships that allow for segregation of G9a inhibition and anti-Plasmodium activity
  作者：Sandeep Sundriyal、Patty B. Chen、Alexandra S. Lubin、Gregor A. Lueg、Fengling Li、Andrew J. P. White、Nicholas A. Malmquist、Masoud Vedadi、Artur Scherf、Matthew J. Fuchter

  DOI：10.1039/c7md00052a

  日期：——

  We identify key SAR features which demonstrate that high parasite vs. G9a selectivity can be achieved for the quinazoline inhibitor chemotype.

  我们确定了关键的 SAR 特征，表明对于喹唑啉抑制剂化学类型，可以实现高寄生虫与 G9a 的选择性。
• Rational Design and Multibiological Profiling of Novel Donepezil–Trolox Hybrids against Alzheimer’s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties
  作者：Pei Cai、Si-Qiang Fang、Xue-Lian Yang、Jia-Jia Wu、Qiao-Hong Liu、Hao Hong、Xiao-Bing Wang、Ling-Yi Kong

  DOI：10.1021/acschemneuro.7b00257

  日期：2017.11.15

  A novel series of donepezil-trolox hybrids were designed, synthesized, and evaluated as multifunctional ligands against Alzheimer’s disease (AD). Biological assays showed that these derivatives possessed moderate to good inhibitory activities against acetylcholinesterase (AChE) and monoamine oxidase B (MAO-B) as well as remarkable antioxidant effects. The optimal compound 6d exhibited balanced functions

  设计，合成和评估了一系列新的多奈哌齐-trolox杂种，作为对抗阿尔茨海默氏病（AD）的多功能配体。生物学测定表明，这些衍生物对乙酰胆碱酯酶（AChE）和单胺氧化酶B（MAO-B）具有中等至良好的抑制活性，并具有显着的抗氧化作用。最佳化合物6d表现出平衡的功能，对h AChE（IC 50 = 0.54μM）和h MAO-B（IC 50 = 4.3μM）具有良好的抑制作用，具有显着的抗氧化活性（通过DPPH方法测得的IC 50为41.33μMIC 50、1.72和1.79 trolox当量通过ABTS和ORAC方法），优异的铜螯合和Aβ1–42聚集抑制作用。此外，细胞测试表明6d具有极低的毒性，并且能够抵抗氧化毒素（H 2 O 2，鱼藤酮和寡霉素-A）引起的神经毒性。最重要的是，在小鼠模型中口服6d表现出对东pol碱引起的急性记忆缺陷以及d-半乳糖（d -gal）和AlCl 3引起的慢性氧化
• Synthesis, radiolabelling, and biodistribution studies of triazole derivatives for targeting melanoma
  作者：Stephanie M. Rathmann、Nancy Janzen、John F. Valliant

  DOI：10.1139/cjc-2016-0239

  日期：2016.9

  Molecular probes that target specific markers expressed in solid tumours are in demand for cancer imaging and radionuclide therapy applications. The synthesis, characterization, and in vivo evaluation of radioiodinated triazoles designed as probes to target melanoma are described here. Compounds were prepared using a thermal click reaction between ethynylstannane and methyl 2-azidoacetate, resulting in preferential formation of the corresponding 1,4-tin triazole. The primary amine of various targeting vectors was then coupled to the resulting tin triazole methyl ester. These precursors were labelled with no carrier added ¹²³I or ¹²⁵I and purified by high performance liquid chromatography to give isolated radiochemical yields between 6% and 51% and radiochemical purities of >95% in all cases. Among the evaluated compounds, N-(2-diethylamino-ethyl)-2-(4-iodo-[1,2,3]triazol-1-yl)acetamide (7a) and N-(1-benzylpiperidin-4-yl)-2-(4-iodo-1H-1,2,3-triazol-1-yl)acetamide (7d) showed the most promising in vivo data, and their ¹²³I-labelled forms were used in single photon emission computed tomography computed tomography (SPECT–CT) imaging studies. The imaging data showed excellent tumour visualization with a very high signal to noise ratio.

  靶向固体肿瘤中特定标记物的分子探针在癌症成像和放射性核素治疗应用中需求旺盛。本文描述了设计为靶向黑色素瘤的三唑类探针的合成、表征和体内评估的放射碘化合物。化合物是通过乙炔基锡烷和甲基2-叠氮乙酸酯之间的热点击反应制备的，导致了相应的1,4-锡三唑的优先形成。然后，各种靶向载体的主氨基与得到的锡三唑甲酯偶联。这些前体物质被标记为无载体添加的¹²³I或¹²⁵I，并通过高效液相色谱纯化，得到的分离放射化学产率在6%至51%之间，所有情况下的放射化学纯度均高于95%。在评估的化合物中，N-(2-二乙氨乙基)-2-(4-碘-[1,2,3]三唑-1-基)乙酰胺（7a）和N-(1-苄哌啶-4-基)-2-(4-碘-1H-1,2,3-三唑-1-基)乙酰胺（7d）展现出最有希望的体内数据，它们的¹²³I标记形式被用于单光子发射计算机断层扫描（SPECT-CT）成像研究。成像数据显示出优秀的肿瘤可视化效果，信噪比非常高。
• 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
  申请人：——

  公开号：US20030105098A1

  公开（公告）日：2003-06-05

  The present invention comprises 6-9-Disubstituted 2-[trans-(4-aminocyclohexyl]aminopurines that are useful in inhibiting cyclin dependent kinases, particularly cdk-2. The present invention also provides a method of preventing apoptosis in neuronal cells and a method of inhibiting the development of neoplasms.

  本发明涉及6-9-二取代的2- [转-（4-氨基环己基）]氨基嘌呤，其在抑制细胞周期依赖性激酶，特别是cdk-2方面具有用途。本发明还提供了一种预防神经细胞凋亡和抑制肿瘤发展的方法。